Starboard's stake in Pfizer 'doesn't make any sense to me at all', says Dartmouth's Paul Argenti

Paul Argenti, Dartmouth Tuck School of Business professor, joins 'Squawk Box' to discuss news of activist investor Starboard Value amassing a roughly $1 billion stake in drugmaker Pfizer, whether Pfizer makes sense as an activist target, and more.